Evogene LtdEvogene LtdEvogene Ltd

Evogene Ltd

No trades
No trades

Price target

624.070.000.00%
The 1 analyst offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Metrics
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Metrics
Reported
Estimate
Surprise
Disclaimer

Frequently asked questions


The current price of EVGN is 169.8 ILA — it has decreased by −1.22% in the past 24 hours. Watch Evogene Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange Evogene Ltd stocks are traded under the ticker EVGN.
EVGN stock has risen by 23.04% compared to the previous week, the month change is a 3.22% rise, over the last year Evogene Ltd has showed a −61.00% decrease.
We've gathered analysts' opinions on Evogene Ltd future price: according to them, EVGN price has a max estimate of 624.07 ILA and a min estimate of 624.07 ILA. Watch EVGN chart and read a more detailed Evogene Ltd stock forecast: see what analysts think of Evogene Ltd and suggest that you do with its stocks.
EVGN reached its all-time high on Jan 1, 2014 with the price of 69,950.0 ILA, and its all-time low was 115.1 ILA and was reached on Jun 26, 2026. View more price dynamics on EVGN chart.
See other stocks reaching their highest and lowest prices.
EVGN stock is 14.62% volatile and has beta coefficient of 0.27. Track Evogene Ltd stock price on the chart and check out the list of the most volatile stocks — is Evogene Ltd there?
Today Evogene Ltd has the market capitalization of ‪19.66 M‬, it has increased by 34.77% over the last week.
Yes, you can track Evogene Ltd financials in yearly and quarterly reports right on TradingView.
Evogene Ltd is going to release the next earnings report on Aug 26, 2026. Keep track of upcoming events with our Earnings Calendar.
EVGN earnings for the last quarter are −1.89 ILA per share, whereas the estimation was −0.85 ILA resulting in a −122.22% surprise. The estimated earnings for the next quarter are −0.80 ILA per share. See more details about Evogene Ltd earnings.
Evogene Ltd revenue for the last quarter amounts to ‪1.05 M‬ ILA, despite the estimated figure of ‪1.10 M‬ ILA. In the next quarter, revenue is expected to reach ‪967.41 K‬ ILA.
EVGN net income for the last quarter is ‪−18.47 M‬ ILS, while the quarter before that showed ‪−16.92 M‬ ILS of net income which accounts for 0.00% change. Track more Evogene Ltd financial stats to get the full picture.
No, EVGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 22, 2026, the company has 52 employees. See our rating of the largest employees — is Evogene Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evogene Ltd EBITDA is ‪−40.67 M‬ ILS, and current EBITDA margin is −335.27%. See more stats in Evogene Ltd financial statements.
Like other stocks, EVGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evogene Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evogene Ltd technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evogene Ltd stock shows the sell signal. See more of Evogene Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.